Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.

Yan Liu
MDS

Gareth Morgan
smoldering myeloma, MGUS

Mark Dawson
B-ALL and CAR-T resistance

Marco Ruella
Immunotherapy for T-cell lymphoma

Yoke Seng Lee
AML

Faron Pharmaceuticals
immunotherapy, MDS

Michael Keller
COVID-19, immunotherapy

ImCheck Therapeutics
immunotherapy, AML

Tycel Phillips
Mantle Cell Lymphoma

Arash Alizadeh
blood cancer biology and diagnosis

John DiPersio
trispecific antibody for AML and MDS

Nicola Vannini
Aging and CAR-T success

Soheil Meshinchi
pediatric AML

Kura Oncology
MLL leukemia, AML

Mark Hamilton
DLBCL and CAR-T

John Leonard
lymphoma research

Jianguo Tao
Mantle Cell Lymphoma

Siddhartha Jaiswal
preleukemia

Takeshi Sugio
T-cell lymphoma

Sigurður Kristinsson
Smoldering myeloma

Ann-Kathrin Eisfeld
Racial diversity in AML

Christopher Porter
Leukemia, lymphoma

Bruno Paiva
smoldering myeloma

Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's

Ronald Levy
immunotherapies, COVID-19

Lucy Godley
preleukemia

Daniel Lucas
bone marrow and leukemia biology

Frederick Locke
lymphoma and immunotherapy

Kerry Rogers
CLL

Sahand Hormoz
MPN

Jennifer Lewis
URM Student

Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL

Noemí Puig Morón
Myeloma

Jonas Jutzi
myeloproliferative neoplasms

Ravi Bhatia
transplantation

Jing Yang
Myeloma

Xu Ji
Equity in Access

Ari Melnick
epigenetics and lymphoma

Simona Colla
Myeloma biology

F. Lennie Wong
Equity in Access

Jayna Mistry
aging and leukemias

Robert Orlowski
(Smoldering) Multiple Myeloma

Stephen Oh
myeloproliferative neoplasms

Yiman Liu
Epigenetics and leukemia

Leandro Cerchietti
DLBCL

Immune-Onc Therapeutics
immunotherapy, AML, CMML

Mala Shanmugam
myeloma

Jessica Stewart
Epstein-barr virus and lymphomas

Daniel Starczynowski
MDS and AML

Jeetayu Biswas
splicing in myeloid diseases

Eugenio Morelli
Myeloma

Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia

Omar Abdel-Wahab
Hairy cell leukemia

Qing Yi
Novel CAR-T

Ruben Carrasco
Myeloma

Jake Shortt
precision therapy for aggressive lymphomas

Alex Kentsis
pediatric leukemias

Piers Patten
COVID-19

Jolanta Grembecka
leukemia therapeutics

Helen Parsons
Equity in Access

Nizar Bahlis
Myeloma immunotherapy

Alexey Danilov
lymphoma

Brian Walker
smoldering myeloma, MGUS

Ryvu Therapeutics
AML, MDS, Myelofibrosis

Nirav Shah
CAR-T for lymphoma

Thomas LeBlanc
palliative care

Lakshmi Nayak
brain tumors in lymphoma

Armin Rashidi
gut bacteria and transplant success

Reina Takeda
AML

Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML

Thomas Kipps
Hairy Cell Leukemia

Caner Saygin
T-ALL

Shazia Nakhoda
Equity in Access

Kirk Schultz
pediatric transplantation

Keisuke Ito
blood cancer stem cells and MDS metabolism

Rizwan Romee
Immunotherapy

Sergei Doulatov
Leukemias

Sisi Chen
leukemia

Alieen Rowan
Adult T cell leukemia/lymphoma

Yubin Zhou
peripheral T cell lymphoma

Roberta Zappasodi
lymphoma, immunotherapy

Tomasz Skorski
myeloproliferative neoplasms, AML

Meng Li
Equity in Access

Suman Paul
T cell cancers and immunotherapy

Ricky Johnstone
lymphoma and myeloma

Enrico Tiacci
Hairy cell leukemia

Alfred Garfall
myeloma immunotherapy

Manyi Wei
acute megakaryoblastic leukemia

Daisuke Nakada
preleukemia, leukemia

Maximilian Stahl
AML immunotherapy

Jaroslaw Maciejewski
bone marrow failure

Thomas Koehnke
leukemia

Adam Olszewski
Follicular and marginal zone lymphoma

Rajni Kumari
AML

Margaret Shipp
lymphoma biology

Steven Horwitz
T-cell lymphomas

Christopher Booth
BPDCN

Catherine Bollard
pediatric blood cancers and immunotherapy

Jeffrey Magee
pediatric AML

Lawrence Boise
CART and myeloma

Matthew Frank
Lymphoma CART therapy

Jun Qi
Myeloma

Catherine Smith
leukemia

Riccardo Dalla-Favera
lymphoma (DLBCL)

Andrew Lane
BPDCN

Anouchka Laurent
T-cell lymphoma

Steven Park
follicular lymphoma

Shannon Maude
Immunotherapy for ALL

Ryan Wilcox
T-cell lymphoma

Anushree Vichare
Equity in Access

James Rubenstein
Lymphoma of the Central Nervous System

Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL

Michael Kharas
leukemia

Coleman Lindsley
AML/MDS

Qingyu Luo
BPDCN

Areej El-Jawahri
transplant survivorship

Paolo Strati
Non-Hodgkin Lymphoma

Carl Allen
pediatric blood cancers

Kasey Leger
pediatric blood cancers

Liling Wan
AML

Courtney DiNardo
clinical trials, AML

Megan McNerney
AML/MDS

Rgenta Therapeutics
RNA-targeting, blood cancer

Catherine Diefenbach
DLBCL immunology

Dimericon Therapeutics
dimericons, blood cancer

Alison Moskowitz
lymphoma therapeutics

Tyler Parsons
MPN and AML

Martin Dreyling
Mantle Cell Lymphoma

Jennifer Woyach
CLL trials

Elliot Stieglitz
CMML

Saar Gill
AML immunotherapy

Daniel Thomas
Myelofibrosis

Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML

Gianpietro Dotti
CAR T and AML

Jonathan Licht
DNA biology, myeloma

John Crispino
MPNs, myelofibrosis

Logan Spector
childhood leukemia epidimiology

Michael Wang
Mantle Cell Lymphoma

Bing Carter
p53 mutant AML

Kimberly Stegmaier
childhood blood cancers

Nitin Jain
CLL

Hong Wen
AML

Nicolas Nassar
pediatric leukemia

Kymera Therapeutics
protein degraders, TCL, LGLL, AML

Roland Walter
Antibody-based AML therapies

Carma Bylund
Equity in Access

Fenghuang Zhan
Myeloma and bone disease

Britta Will
Leukemia and pre-leukemia

Eric Padron
CMML

BioInvent International
immunotherapy, indolent NHL, CTCL

Marina Konopleva
MDS/AML metabolism

Jaehyuk Choi
T-cell lymphoma

Robert Soiffer
transplantation

Tak Mak
Immunotherapy

Steven Treon
Lymphomas and Waldenstrom's

Mark Murakami
follicular lymphoma

Wendy Stock
T-cell ALL

Luca Busino
DLBCL

Lori Muffly
Equity in Access

Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial

Christian Steidl
B-cell lymphomas

Yibin Yang
Lymphoma

George Vassiliou
Leukemia Prevention

Catriona Jamieson
cancer stem cell biology

Dan Landau
cancer evolution biology

Trent Hall
MDS

Brian Dalton
DNA mutations and myeloid cancers

Matteo Bellone
Smoldering multiple myeloma

Michaela Reagan
Multiple Myeloma

Bingyi Chen
AML immunotherapy

Nataly Cruz-Rodriguez
T-ALL and metabolism

Randall Davis
CLL

Timothy Graubert
AML and MDS biology

Julia Maxson
AML

Adam de Smith
pediatric ALL and Down Syndrome

Amit Verma
AML/MDS

Jing Fu
myeloma

Jonathon Cohen
lymphoma clinical trial access in Georgia

Pietro Genovese
transplant and AML

Stacie Dusetzina
Equity in Access

Srividya Swaminathan
pediatric, immunotherapy

Jianhua Yu
myeloma immunotherapy

Caroline Arber
myeloma CAR-T

Neha Mehta-Shah
T-cell lymphoma

Dane Vassiliadis
blood cancer biology

Taishi Yonezawa
AML

Grant Challen
preleukemia, leukemia

Bailee Kain
AML and African ancestry

Paolo Caimi
CAR-T clinical trial for CLL

Daniel Herranz
T-ALL

Julia Paczkowska
immunobiology of Hodgkin's disease

Jane Oliaro
Myeloma & Lymphoma Immunotherapy

Huda Salman
CMML

Siegfried Janz
Myeloma immunotherapy

Raymond Mailhot
Equity in Access

Christine Zhang
AML

Michael Green
lymphoma biology

Craig Jordan
AML

Pooja Khandelwal
bone marrow transplantation

Lev Kats
myeloma and epigenetics

Oreofe Odejide
Equity in Access

Christopher Flowers
clinical trial access

H. Irene Su
Equity in Access

Ana Vujovic
AML

Philippe Armand
follicular lymphoma

Teresa Palomero
Peripheral T-cell Lymphoma

Courtney Jones
AML metabolism

Caron Jacobson
lymphoma and immunotherapy

Lei Ding
myeloproliferative neoplasms, myelofibrosis

Anita Kumar
Mantle Cell Lymphoma immunotherapy

Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients

Sham Mailankody
Myeloma immunotherapy clinical trials

Suzanne Lentzsch
Myeloma

Sarah Tasian
pediatric leukemias

Hao Jiang
DNA biology and leukemia

Venkata Lokesh Battula
immunotherapy and AML

Sam Butterworth
CMML

Markus Muschen
leukemia and lymphoma biology

Paul Beavis
immunotherapy in myeloma

William Matsui
Myeloma

Inhye Ahn
CLL

Fahmin Basher
transplant and GvHD

George Daley
"off-the-shelf" CAR-T and CAR-NK

Solu Therapeutics
immunotherapy, CMML

Eirini Papapetrou
blood cancer stem cells

Sriram Sundaravel
AML stem cells

Cailin Collins
Leukemia and pre-leukemia

Enterome
vaccine, FL, MZL

Gaurav Goyal
Erdheim-Chester Disease

Daniel Pollyea
AML

Amin Sobh
Myeloma biology

Wendy Béguelin
follicular lymphoma

Anthony Letai
improving CAR-T

Constantine Mitsiades
CAR-T and CAR-NK immunotherapies

Peter Croucher
Multiple Myeloma

Sheng Li
Aging and AML

Marc Seifert
Hairy cell leukemia

Jean Koff
Disparities in DLBCL

Joachim Yahalom
Lymphoma

Affimed
immunotherapy, HL, PTCL

Peter Klein
MDS

Liran Shlush
pre-leukemia

Grzegorz Nowakowski
Clinical trial access

Susan Schwab
cancer immunology

Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy

Jalpa Doshi
Equity in Access

Jeremy Baeten
AML

Jenny Wang
AML

Jennifer Trowbridge
aging and leukemia

Ravindra Majeti
preleukemia, AML

Lindsey Montefiori
pediatric leukemia

Mendel Goldfinger
MDS/AML trials for the elderly

Eric Pietras
AML

Koichi Takahashi
AML/MDS

Frederike Kramer
MPNs

Christian Marinaccio
MLL leukemias

Nicoletta Cieri
AML and transplantation

Michael Savona
MDS and leukemia

Carl June
CAR T immunotherapy

Ramon Massoni-Badosa
CLL and Richter's Syndrome

Kathleen Sakamoto
pediatric AML

Constellation Pharmaceuticals
myeloproliferative neoplasms

Alec Zhang
myeloma, immunotherapy

Tanya Siddiqi
clinical trial access

Stephen Gottschalk
pediatric leukemia and CAR-T

Madhav Dhodapkar
multiple myeloma immunotherapy

Adi Nagler
Bronchiolitis obliterans after transplant

Rong Lu
preleukemia, leukemia

Stephen Nimer
myeloid cancer biology

Justine Kahn
pediatric leukemia and lymphoma

Richard Lock
T-ALL